Recently, the State Drug Administration announced on its website that it agreed to accept Olymvax's application to conduct clinical trials of quadrivalent influenza virus cracking vaccine, marking new progress in Olymvax's first product pipeline of virus-based vaccines.

Influenza (also known as influenza) is an acute respiratory infection caused by influenza viruses, spread by respiratory droplets and contact, and the population is generally susceptible. Influenza poses a significant burden on global public health, and vaccination is the most effective way to reduce this burden. Vaccination with quadrivalent influenza virus lysate vaccine can stimulate the body to produce anti-influenza virus immunity, and is used to prevent influenza caused by vaccine-associated types of influenza viruses.

Currently, most of the influenza vaccines available in China are based on chicken embryos. The influenza vaccine developed by Olymvax is based on MDCK cell mass culture technology, which can realize higher production yield, more stable product quality and lower production cost through mass culture in bioreactors.

Olymvax has been deeply cultivating in the field of bacterial vaccines for many years, and has obtained efficient industrial transformation results. Quadrivalent influenza virus lysate vaccine is the company's first product pipeline in viral vaccines. Through influenza vaccine research and development, the company has successfully built up a viral vaccine research and development team and technology platform. The acceptance of the clinical trial of quadrivalent influenza virus lysate vaccine indicates that the Company has made a new breakthrough in the field of viral vaccines, which is conducive to the further extension of the Company's R&D pipeline, enriching the Company's product layout and laying a solid foundation for the Company's high-quality and sustainable development. The Company will continue to promote the clinical trial project of quadrivalent influenza virus lysate vaccine, strive to complete the relevant research as soon as possible, realize the product listing, and contribute Oulin's strength to the domestic health cause.

https://mp.weixin.qq.com/s/vO3PuFXuvWToWji9TwNowA